Clinical Trial Update: Obesity, Weight Loss, and Cardiovascular Disease Risk [NA]

View source ↗

Summary

This is a completed clinical trial update from Stanford University. It focuses on obesity, weight loss, and cardiovascular disease risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Obesity

Snippet

Sponsor: Stanford University | Conditions: Obesity | NA | Status: COMPLETED